Why This Biotech Stock Has 'Limited Downside' After 22% Gain This YearInvestors Business Daily • 09/05/19
Incyte Corporation's (INCY) CEO Hervé Hoppenot on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/30/19
Incyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater ChinaMarket Watch • 07/02/19